Annual Short Term Debt
$7.56 M
-$350.00 K-4.43%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual short term debt is $7.56 million, with the most recent change of -$350.00 thousand (-4.43%) on December 1, 2024.
- During the last 3 years, TRDA annual short term debt has risen by +$7.56 million (+100.00%).
- TRDA annual short term debt is now -10.08% below its all-time high of $8.41 million, reached on December 31, 2022.
Performance
TRDA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$7.56 M
-$179.00 K-2.31%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly short term debt is $7.56 million, with the most recent change of -$179.00 thousand (-2.31%) on December 1, 2024.
- Over the past year, TRDA quarterly short term debt has stayed the same.
- TRDA quarterly short term debt is now -11.77% below its all-time high of $8.57 million, reached on June 30, 2024.
Performance
TRDA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TRDA Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.4% | 0.0% |
| 3 y3 years | +100.0% | -10.1% |
| 5 y5 years | - | -10.1% |
TRDA Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | -100.0% | -11.8% | -100.0% |
| 5 y | 5-year | -10.1% | -100.0% | -11.8% | -100.0% |
| alltime | all time | -10.1% | -100.0% | -11.8% | -100.0% |
Entrada Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $7.56 M(-4.4%) | $7.56 M(-2.3%) |
| Sep 2024 | - | $7.74 M(-9.7%) |
| Jun 2024 | - | $8.57 M(+3.2%) |
| Mar 2024 | - | $8.30 M(+5.0%) |
| Dec 2023 | $7.91 M | $7.91 M(+19.1%) |
| Sep 2023 | - | $6.64 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $7.41 M(+4.3%) |
| Mar 2023 | - | $7.10 M(-15.5%) |
| Dec 2022 | $8.41 M(>+9900.0%) | $8.41 M(+1.8%) |
| Sep 2022 | - | $8.26 M(+1.8%) |
| Jun 2022 | - | $8.11 M(+1.8%) |
| Mar 2022 | - | $7.97 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Entrada Therapeutics annual short term debt?
- What is the all time high annual short term debt for Entrada Therapeutics?
- What is Entrada Therapeutics annual short term debt year-on-year change?
- What is Entrada Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly short term debt year-on-year change?
What is Entrada Therapeutics annual short term debt?
The current annual short term debt of TRDA is $7.56 M
What is the all time high annual short term debt for Entrada Therapeutics?
Entrada Therapeutics all-time high annual short term debt is $8.41 M
What is Entrada Therapeutics annual short term debt year-on-year change?
Over the past year, TRDA annual short term debt has changed by -$350.00 K (-4.43%)
What is Entrada Therapeutics quarterly short term debt?
The current quarterly short term debt of TRDA is $7.56 M
What is the all time high quarterly short term debt for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly short term debt is $8.57 M
What is Entrada Therapeutics quarterly short term debt year-on-year change?
Over the past year, TRDA quarterly short term debt has changed by $0.00 (0.00%)